Journal of Substance Abuse Treatment
Volume 35, Issue 1 , Pages 22-27 , July 2008

Internet access to Salvia divinorum: Implications for policy, prevention, and treatment

  • Valerie Hoover, B.A.

      Affiliations

    • Treatment Research Institute at the University of Pennsylvania, 150 South Independence Mall West, Philadelphia, PA 19106, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 202 686 2210x378; fax: +1 202 686 0094.
    • ,
  • Douglas B. Marlowe, J.D., Ph.D.

      Affiliations

    • Treatment Research Institute at the University of Pennsylvania, 150 South Independence Mall West, Philadelphia, PA 19106, USA
    • School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Nicholas S. Patapis, Psy.D., M.A.C.J.

      Affiliations

    • Treatment Research Institute at the University of Pennsylvania, 150 South Independence Mall West, Philadelphia, PA 19106, USA
    • ,
  • David S. Festinger, Ph.D.

      Affiliations

    • Treatment Research Institute at the University of Pennsylvania, 150 South Independence Mall West, Philadelphia, PA 19106, USA
    • ,
  • Robert F. Forman, Ph.D.

      Affiliations

    • Alkermes, Inc., Cambridge, MA 02139, USA

Received 26 October 2006 ,Revised 23 July 2007 ,Accepted 24 July 2007.

References 

  1. Bigham AK, Munro TA, Rizzacasa MA, Robins-Browne RM. Divinatorins A–C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum. Journal of Natural Products. 2003;66:1242–1244
  2. Bucheler R, Gleiter CH, Schwoerer P, Gaertner I. Use of non-prohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (diviner's sage). Pharmacopsychiatry. 2005;38:1–5
  3. Butelman ER, Harris TJ, Kreek MJ. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology. 2004;172:220–224
  4. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ. Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum, is a highly efficacious κ-opioid receptor agonist: Structural and functional considerations. Journal of Pharmacology and Experimental Therapeutics. 2004;308:1197–1203
  5. Comprehensive Drug Control Act of 1989, Missouri Rev. Stat., Chapter 195. 2005 & Supp. 2006.
  6. Drug Enforcement Administration, 2005. Drugs and chemicals of concern. At: http://www.deadiversion.usdoj.gov/drugs_concern/salvia_d/salvia_d.htm. Accessed on: October 23, 2005.
  7. Drug Enforcement Administration. 2006. Briefs and Background, Drugs and Drug Abuse, Drug Descriptions, Steroids Factsheet. Retrieved April 26, 2006 from http://www.dea.gov/concern/steroids_factsheet.html.
  8. Forman RF. Availability of opioids on the Internet. Journal of the American Medical Association. 2003;290:889
  9. Forman RF, Woody GD, McLellan AT. The availability of websites offering to sell opioid medications without prescriptions. American Journal of Psychiatry. 2006;163:1233–1238
  10. Forman RF, Marlowe DB, McLellan AT. The Internet as a source of drugs of abuse. Current Psychiatry Report. 2006;8:377–382
  11. Giroud C, Felber F, Augsburger M, Horisberger B, Rivier L, Mangin P. Salvia divinorum: An hallucinogenic mint which might become a new recreational drug in Switzerland. Forensic Science International. 2004;112:143–150
  12. Gonzalez D, Riba J, Bouso JC, Gomez-Jarabo G, Barbanoj MJ. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence. 2006;85:157–162
  13. Gordon S, Forman R, Siatkowski C. Internet as dealer: Knowledge and use of the Internet as a source of illicit drugs. Journal of Substance Abuse Treatment. 2006;30:271–274
  14. Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics. 2004;102:131–138
  15. Halpern JH, Pope HG. Hallucinogens on the Internet: A vast new source of underground drug information. American Journal of Psychiatry. 2001;158:481–483
  16. Imanshahidi M, Hosseinzadeh H. The pharmacological effects of Salvia species on the central nervous system. Phytotherapy Research. 2006;20:427–437
  17. Izenwasser S, Acri JB, Kunko PM, Shippenberg T. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse. 1998;30:275–283
  18. Lee DY, Ma Z, Liu-Chen LY, Wang Y, Chen Y, Carlezon WA, et al. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors. Bioorganic and Medicinal Chemistry. 2005;13:5635–5639
  19. Munro TA, Rizzacasa MA, Roth BL, Toth BA, Yan F. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist. Journal of Medicinal Chemistry. 2005;48:345–348
  20. National Institute on Drug Abuse. . NIDA Research Report Series: Anabolic Steroid Abuse (NIH Publication No. 00-3721). Washington, DC: U.S. Department of Health and Human Services; 2000;
  21. Partnership for a Drug-Free America (news release). Generation Rx: National study reveals new category of substance abuse emerging: Teens abusing Rx and OTC medications intentionally to get high. April 21, 2005. At: http://www.drugfree.org/Portal/About/NewsReleases/Generation_Rx_Teens_Abusing_Rx_and_OTC_Medications Accessed June 20, 2005.
  22. Pichini S, Abanades S, Farre M, Pellegrini M, Marchei E, Pacifici R. Quantification of the plant-derived hallucinogen salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking. Rapid Communications in Mass Spectrometry. 2005;19:1649–1656
  23. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, et al. Salvinorin A: A potent naturally occurring non-nitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences. 2002;99:11934–11939
  24. Siebert, D. (2005). The Salvia divinorum user's guide. At: http://sagewisdom.org/usersguide.html. Accessed August 11, 2006.
  25. Uniform Controlled Substances Act, 16 Del. Stat. Ann. §§ 4711 et seq. 2006.
  26. United States Government Accountability Office . Anabolic steroids are easily purchased without a prescription and present significant challenges to law enforcement officials (GA0-06-243R). Washington, DC: U.S. Government Accountability Office; 2005;
  27. U.S. General Accounting Office, 2004, June. Internet pharmacies: Hydrocodone, an addictive narcotic pain medication is available without a prescription through the Internet. Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate.
  28. Valdes LJ. Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin). Journal of Psychoactive Drugs. 1994;26:277–283

PII: S0740-5472(07)00224-3

doi: 10.1016/j.jsat.2007.07.011

Journal of Substance Abuse Treatment
Volume 35, Issue 1 , Pages 22-27 , July 2008

Article Tools